Pharmaron Beijing (China) Market Value

300759 Stock   26.72  1.66  5.85%   
Pharmaron Beijing's market value is the price at which a share of Pharmaron Beijing trades on a public exchange. It measures the collective expectations of Pharmaron Beijing Co investors about its performance. Pharmaron Beijing is trading at 26.72 as of the 22nd of November 2024, a 5.85 percent decrease since the beginning of the trading day. The stock's open price was 28.38.
With this module, you can estimate the performance of a buy and hold strategy of Pharmaron Beijing Co and determine expected loss or profit from investing in Pharmaron Beijing over a given investment horizon. Check out Pharmaron Beijing Correlation, Pharmaron Beijing Volatility and Pharmaron Beijing Alpha and Beta module to complement your research on Pharmaron Beijing.
Symbol

Please note, there is a significant difference between Pharmaron Beijing's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharmaron Beijing is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharmaron Beijing's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Pharmaron Beijing 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharmaron Beijing's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharmaron Beijing.
0.00
10/23/2024
No Change 0.00  0.0 
In 31 days
11/22/2024
0.00
If you would invest  0.00  in Pharmaron Beijing on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Pharmaron Beijing Co or generate 0.0% return on investment in Pharmaron Beijing over 30 days. Pharmaron Beijing is related to or competes with Shenzhen Bioeasy, Namchow Food, Jinhe Biotechnology, Ningbo MedicalSystem, New Hope, Juewei Food, and Sichuan Teway. Pharmaron Beijing is entity of China. It is traded as Stock on SHE exchange. More

Pharmaron Beijing Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharmaron Beijing's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharmaron Beijing Co upside and downside potential and time the market with a certain degree of confidence.

Pharmaron Beijing Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmaron Beijing's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharmaron Beijing's standard deviation. In reality, there are many statistical measures that can use Pharmaron Beijing historical prices to predict the future Pharmaron Beijing's volatility.
Hype
Prediction
LowEstimatedHigh
23.0028.3833.76
Details
Intrinsic
Valuation
LowRealHigh
18.1123.4928.87
Details
Naive
Forecast
LowNextHigh
22.7128.0933.47
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.230.250.28
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pharmaron Beijing. Your research has to be compared to or analyzed against Pharmaron Beijing's peers to derive any actionable benefits. When done correctly, Pharmaron Beijing's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Pharmaron Beijing.

Pharmaron Beijing Backtested Returns

Pharmaron Beijing appears to be not too volatile, given 3 months investment horizon. Pharmaron Beijing maintains Sharpe Ratio (i.e., Efficiency) of 0.13, which implies the firm had a 0.13% return per unit of risk over the last 3 months. By analyzing Pharmaron Beijing's technical indicators, you can evaluate if the expected return of 0.73% is justified by implied risk. Please evaluate Pharmaron Beijing's Semi Deviation of 3.55, risk adjusted performance of 0.0959, and Coefficient Of Variation of 872.35 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pharmaron Beijing holds a performance score of 10. The company holds a Beta of -0.84, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Pharmaron Beijing are expected to decrease at a much lower rate. During the bear market, Pharmaron Beijing is likely to outperform the market. Please check Pharmaron Beijing's market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to make a quick decision on whether Pharmaron Beijing's historical price patterns will revert.

Auto-correlation

    
  0.16  

Very weak predictability

Pharmaron Beijing Co has very weak predictability. Overlapping area represents the amount of predictability between Pharmaron Beijing time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharmaron Beijing price movement. The serial correlation of 0.16 indicates that over 16.0% of current Pharmaron Beijing price fluctuation can be explain by its past prices.
Correlation Coefficient0.16
Spearman Rank Test-0.56
Residual Average0.0
Price Variance2.4

Pharmaron Beijing lagged returns against current returns

Autocorrelation, which is Pharmaron Beijing stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharmaron Beijing's stock expected returns. We can calculate the autocorrelation of Pharmaron Beijing returns to help us make a trade decision. For example, suppose you find that Pharmaron Beijing has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Pharmaron Beijing regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharmaron Beijing stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharmaron Beijing stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharmaron Beijing stock over time.
   Current vs Lagged Prices   
       Timeline  

Pharmaron Beijing Lagged Returns

When evaluating Pharmaron Beijing's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharmaron Beijing stock have on its future price. Pharmaron Beijing autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharmaron Beijing autocorrelation shows the relationship between Pharmaron Beijing stock current value and its past values and can show if there is a momentum factor associated with investing in Pharmaron Beijing Co.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Pharmaron Stock

Pharmaron Beijing financial ratios help investors to determine whether Pharmaron Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaron with respect to the benefits of owning Pharmaron Beijing security.